Intestinal tumour chemoprevention with the antioxidant lipoic acid stimulates the growth of breast cancer

European Journal of Cancer

Volumn 44, Issue 17, 2008, Pages 2696-2704

  Rossi, Cosmo ^a   Di Lena, Annalisa ^a   La Sorda, Rossana ^b   Lattanzio, Rossano ^b   Antolini, Laura ^c   Patassini, Cristina ^b   Piantelli, Mauro ^b   Alberti, Saverio ^b  

^a Consorzio Mario Negri Sud ^*  (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Antioxidants; Breast cancer; Chemoprevention; Experimental tumour models; Intestinal tumours

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL STIMULATION; CHEMOPROPHYLAXIS; COLON POLYPOSIS; CONTROLLED STUDY; DISEASE CONTROL; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; GENE OVEREXPRESSION; GROWTH INHIBITION; GROWTH RATE; HISTOPATHOLOGY; INTESTINE TUMOR; MALE; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; RISK REDUCTION; TUMOR DIFFERENTIATION; TUMOR MODEL; WEANING; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BREAST NEOPLASMS; FEMALE; INTESTINAL NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; RANDOM ALLOCATION; THIOCTIC ACID;

EID: 55549113156     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.08.021     Document Type: Article

References (52)

1. Steinmetz K.A., and Potter J.D. Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 96 (1996) 1027-1039
2. Touillaud M.S., Thiebaut A.C., Fournier A., Niravong M., Boutron-Ruault M.C., and Clavel-Chapelon F. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J Natl Cancer Inst 99 (2007) 475-486
3. Larsson S.C., Bergkvist L., and Wolk A. Fruit and vegetable consumption and incidence of gastric cancer: a prospective study. Cancer Epidemiol Biomark Prev 15 (2006) 1998-2001
4. Hung H.C., Joshipura K.J., Jiang R., et al. Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst 96 (2004) 1577-1584
5. Plummer M., Vivas J., Lopez G., et al. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population. J Natl Cancer Inst 99 (2007) 137-146
6. Piantelli M., Rossi C., Iezzi M., et al. Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions. J Cell Physiol 207 (2006) 23-29
7. Bjelakovic G., Nikolova D., Simonetti R.G., and Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 364 (2004) 1219-1228
8. Albanes D., Heinonen O.P., Taylor P.R., et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 88 (1996) 1560-1570
9. You W.C., Brown L.M., Zhang L., et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 98 (2006) 974-983
10. Bairati I., Meyer F., Gelinas M., et al. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst 97 (2005) 481-488
11. Frank S.A. Age-specific incidence of inherited versus sporadic cancers: a test of the multistage theory of carcinogenesis. Proc Natl Acad Sci USA 102 (2005) 1071-1075
12. Muller W.J., Sinn E., Pattengale P.K., Wallace R., and Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54 (1988) 105-115
13. De Vita V.T., Hellman S., and Rosenberg S.A. Cancer - principles and practice of oncology. VIth ed. (2001), Lippincott J.B. Co., Philadelphia
14. Guy C.T., Webster M.A., Schaller M., Parsons T.J., Cardiff R.D., and Muller W.J. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89 (1992) 10578-10582
15. Siegel P.M., Dankort D.L., Hardy W.R., and Muller W.J. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol Cell Biol 14 (1994) 7068-7077
16. Sieber O.M., Tomlinson I.P., and Lamlum H. The adenomatous polyposis coli (APC) tumour suppressor-genetics, function and disease. Mol Med Today 6 (2000) 462-469
17. Packer L., Witt E.H., and Tritschler H.J. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 19 (1995) 227-250
18. Moini H., Packer L., and Saris N.E. Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol 182 (2002) 84-90
19. Pierce R.H., Campbell J.S., Stephenson A.B., et al. Disruption of redox homeostasis in tumor necrosis factor-induced apoptosis in a murine hepatocyte cell line. Am J Pathol 157 (2000) 221-236
20. Wakai K., Hirose K., Matsuo K., et al. Dietary risk factors for colon and rectal cancers: a comparative case-control study. J Epidemiol 16 (2006) 125-135
21. Di Leo A., Messa C., Cavallini A., and Linsalata M. Estrogens and colorectal cancer. Curr Drug Targets Immune Endocrinol Metabol Disord 1 (2001) 1-12
22. Zhao X., Goswami M., Pokhriyal N., et al. Cyclooxygenase-2 expression during immortalization and breast cancer progression. Cancer Res 68 (2008) 467-475
23. Masferrer J.L., Leahy K.M., Koki A.T., et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60 (2000) 1306-1311
24. Tomayko M.M., and Reynolds C.P. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24 (1989) 148-154
25. Moser A.R., Pitot H.C., and Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247 (1990) 322-324
26. Moser A.R., Mattes E.M., Dove W.F., Lindstrom M.J., Haag J.D., and Gould M.N. ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc Natl Acad Sci USA 90 (1993) 8977-8981
27. Rodenhiser D.I. Epigenetic contributions to cancer metastasis. Clin Exp Metastasis 100 (2008) 1-14
28. Ushijima T. Epigenetic field for cancerization. J Biochem Mol Biol 40 (2007) 142-150
29. Martinez-Sanchez G., and Giuliani A. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development. J Exp Clin Cancer Res 26 (2007) 39-50
30. Christofori G. New signals from the invasive front. Nature 441 (2006) 444-450
31. Christofori G. Cancer: division of labour. Nature 446 (2007) 735-736
32. Regina Todeschini A., and Hakomori S.I. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta 1780 (2008) 421-433
33. Voehringer D.W., Hirschberg D.L., Xiao J., et al. Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. Proc Natl Acad Sci USA 97 (2000) 2680-2685
34. Tacchini L., Dansi P., Matteucci E., and Desiderio M.A. Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis 22 (2001) 1363-1371
35. King-Batoon A., Leszczynska J.M., and Klein C.B. Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ Mol Mutagen 49 (2008) 36-45
36. Campos A.C., Molognoni F., Melo F.H., et al. Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation. Neoplasia 9 (2007) 1111-1121
37. Lao C.D., and Brenner D.E. Strategies for prevention of colorectal cancer: pharmaceutical and nutritional interventions. Curr Treat Options Oncol 5 (2004) 417-426
38. Menard S., Aiello P., Tagliabue E., et al. Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model. Cancer Res 60 (2000) 273-275
39. Ritland S.R., and Gendler S.J. Chemoprevention of intestinal adenomas in the ApcMin mouse by piroxicam: kinetics, strain effects and resistance to chemosuppression. Carcinogenesis 20 (1999) 51-58
40. Luongo C., Moser A.R., Gledhill S., and Dove W.F. Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 54 (1994) 5947-5952
41. Jen J., Powell S.M., Papadopoulos N., et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res 54 (1994) 5523-5526
42. Powis G., Kirkpatrick D.L., Angulo M., and Baker A. Thioredoxin redox control of cell growth and death and the effects of inhibitors. Chem Biol Interact 111-112 (1998) 23-34
43. Matthews J.R., Wakasugi N., Virelizier J.L., Yodoi J., and Hay R.T. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 20 (1992) 3821-3830
44. Chinery R., Brockman J.A., Dransfield D.T., and Coffey R.J. Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein beta. A critical role for protein kinase A-mediated phosphorylation of Ser299. J Biol Chem 272 (1997) 30356-30361
45. 2 and TNF alpha. Differences between in vivo and in vitro effects. FEBS Lett 416 (1997) 381-386
46. Hayashi S., Hajiro-Nakanishi K., Makino Y., Eguchi H., Yodoi J., and Tanaka H. Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. Nucleic Acids Res 25 (1997) 4035-4040
47. Nakamura K., Hori T., Sato N., Sugie K., Kawakami T., and Yodoi J. Redox regulation of a src family protein tyrosine kinase p56lck in T cells. Oncogene 8 (1993) 3133-3139
48. Nakamura H., Nakamura K., and Yodoi J. Redox regulation of cellular activation. Ann Rev Immunol 15 (1997) 351-369
49. Chen Q., Espey M.G., Sun A.Y., et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci USA (2008)
50. Pfeffer U., Ferrari N., Morini M., Benelli R., Noonan D.M., and Albini A. Antiangiogenic activity of chemopreventive drugs. Int J Biol Mark 18 (2003) 70-74
51. Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., and Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24 (2004) 2783-2840
52. Narayanan B.A. Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets. Curr Cancer Drug Targets 6 (2006) 711-727